All (N = 199) | Died (N = 20) | Survived (N = 179) | p-value | ||||
---|---|---|---|---|---|---|---|
n | n(%) or median(IQR) | n | n(%) or median(IQR) | n | n(%) or median(IQR) | ||
Age, years | 197 | 30.8 (24.7–41.3) | 20 | 43.5 (30.3–54.8) | 177 | 30.2 (23.9–38.9) | 0.0003 |
BMI | 117 | 24.9 (21.3–29.7) | 6 | 23.6 (22.7–24.1) | 111 | 25.3 (21.3–30.0) | 0.29 |
Gender, Male | 199 | 127 (63.8%) | 20 | 13 (65%) | 179 | 114 (63.7%) | 0.91 |
Presence of any co-morbidity | 198 | 62 (31.2%) | 20 | 9 (45%) | 178 | 53 (29.6%) | 0.16 |
Co-morbidity | |||||||
COPD/BA | 9 (4.6%) | 0 (0%) | 9 (5.1%) | ||||
DM | 24 (12.1%) | 5 (25%) | 19 (10.7%) | ||||
Hypertension | 9 (4.6%) | 2 (10%) | 7 (3.9%) | ||||
IHD | 2 (1%) | 1 (5%) | 1 (0.6%) | ||||
Pregnancy | 8 (4%) | 1 (5%) | 7 (3.9%) | ||||
Others | 10 (5.1%) | 0 (0%) | 10 (5.6%) | ||||
Multiple co-morbidities | 198 | 20 (10.1%) | 20 | 5 (25%) | 178 | 15 (8.4%) | 0.04a |
NS1 | 198 | 132 (66.7%) | 20 | 13 (65%) | 178 | 119 (66.9%) | 0.87 |
High-titre IgG | 198 | 47 (23.7%) | 20 | 5 (25%) | 178 | 42 (23.6%) | 0.89 |
IgM | 198 | 115 (58.1%) | 20 | 14 (70%) | 178 | 101 (56.7%) | 0.25 |
Persistent vomiting | 198 | 114 (57.6%) | 20 | 14 (70%) | 178 | 100 (56.2%) | 0.24 |
Abdominal pain | 198 | 89 (45%) | 20 | 7 (35%) | 178 | 82 (46.1%) | 0.35 |
Lethargy | 198 | 96 (48.5%) | 20 | 15 (75%) | 178 | 81 (45.5%) | 0.01 |
Palpable liver | 198 | 16 (8.1%) | 20 | 2 (10%) | 178 | 14 (7.9%) | 0.67a |
Fluid accumulation | 198 | 44 (22.2%) | 20 | 4 (20%) | 178 | 40 (22.5%) | 1.00a |
Bleed | 198 | 49 (24.8%) | 20 | 13 (65%) | 178 | 36 (20.2%) | < 0.0001a |
Hct > 46 | 198 | 77 (38.9%) | 20 | 10 (50%) | 178 | 67 (37.6%) | 0.28 |
Low Plt < 46 | 198 | 106 (53.5%) | 20 | 15 (75%) | 178 | 91 (51.1%) | 0.04 |
Albumin < 34 | 198 | 106 (53.5%) | 20 | 13 (65%) | 178 | 93 (52.3%) | 0.28 |
Number of warning signs | 199 | 20 | 179 | NSb | |||
0 | 9 (4.5%) | 0 (0%) | 9 (5.03%) | ||||
1 | 17 (8.5%) | 0 (0%) | 17 (9.5%) | ||||
2 | 35 (17.6%) | 2 (10%) | 33 (18.4%) | ||||
3 | 35 (17.6%) | 4 (20%) | 31 (17.3%) | ||||
4 | 49 (24.6%) | 6 (30%) | 43 (24.0%) | ||||
5 | 29 (14.6%) | 2 (10%) | 27 (15.1%) | ||||
6 | 16 (8%) | 3 (15%) | 13 (7.3%) | ||||
7 | 5 (2.5%) | 0 (0%) | 5 (2.8%) | ||||
8 | 3 (1.5%) | 2 (10%) | 1 (0.6%) | ||||
9 | 1 (0.5%) | 1 (5%) | 0 (0%) | ||||
Presence of any warning signs | 198 | 190 (95.5%) | 20 | 20 (100%) | 178 | 170 (95.0%) | 1.00a |
Severe dengue by type | |||||||
Decompensated shock | 58 (29.1%) | 10 (50%) | 48 (26.8%) | ||||
Compensated shock | 69 (34.7%) | 4 (20%) | 65 (36.3%) | ||||
Respiratory compromise | 42 (21.1%) | 2 (10%) | 40 (22.3%) | ||||
Severe bleeding | 24 (12.1%) | 10 (50%) | 14 (7.8%) | ||||
Severe hepatitis | 40 (20.1%) | 8 (40%) | 32 (17.9%) | ||||
AKI | 35 (17.6%) | 8 (40%) | 27 (15.1%) | ||||
Encephalitis | 6 (3.0%) | 2 (10%) | 4 (2.2%) | ||||
Other | 5 (2.5%) | 1 (5%) | 4 (2.2%) | ||||
Number of types of severe dengue | NSb | ||||||
1 | 139 (69.8%) | 12 (60%) | 127 (70.9%) | ||||
2 | 53 (26.6%) | 4 (20%) | 49 (27.4%) | ||||
3 | 5 (2.5%) | 3 (15%) | 2 (1.1%) | ||||
4 | 2 (1.0%) | 1 (5%) | 1 (0.6%) | ||||
Blood products given | 198 | 57 (28.8%) | 20 | 18 (90%) | 178 | 39 (21.9%) | < 0.0001 |
SBP, mmHg | 198 | 103 (90–120) | 20 | 98 (87–133) | 178 | 103 (90–118) | 0.88 |
DBP, mmHg | 198 | 63 (53–74) | 20 | 60.5 (48–84) | 178 | 63 (54–74) | 0.92 |
MAP, mmHg | 198 | 77 (65–89) | 20 | 74.3 (61–102) | 178 | 77.3 (66–88) | 0.96 |
PR, beats per minute | 197 | 98 (86–110) | 20 | 110 (102–120) | 177 | 96 (86–109) | 0.01 |
Shock Index, bpm/mmHg | 197 | 1.2 (1.0–1.5) | 20 | 1.3 (1.0–1.9) | 177 | 1.2 (1.0–1.4) | 0.25 |
RR, breaths/min | 182 | 20 (18–24) | 20 | 22 (19–30) | 162 | 20(18–23) | 0.07 |
WBC, ×103/μL | 198 | 4.2 (2.9–5.7) | 20 | 5.3 (2.7–8.4) | 178 | 4.1 (2.9–5.6) | 0.15 |
Hb, g/dL | 198 | 14.2(12.3–16.2) | 20 | 13.9 (11.7–17.1) | 178 | 14.2 (12.3–16.1) | 0.97 |
Hct, % | 198 | 42 (37–47.0) | 20 | 42.5 (31.0–49.5) | 178 | 42 (37.0–47.0) | 0.91 |
Platelet, × 103/μL | 197 | 43 (16–97) | 20 | 26 (8–41) | 177 | 53 (18–105) | 0.005 |
Serum creatinine, μmol/L | 195 | 79 (63–101) | 20 | 110 (67–333) | 175 | 75 (63–97) | 0.01 |
AST, U/L | 184 | 165 (66–600) | 19 | 1175 (123–1920) | 165 | 152 (63–456) | 0.01 |
ALT, U/L | 192 | 104 (34–257) | 20 | 365 (62–755) | 172 | 95 (31–211) | 0.01 |
Troponin T, ng/mL | 17 | 0.02 (0.009–0.3) | 6 | 0.4 (0.05–1.9) | 11 | 0.009 (0.007–0.03) | 0.10 |
Serum bicarbonate, mmol/L | 192 | 21.1 (18.5–23.1) | 20 | 16.2 (11.2–18.8) | 172 | 21.5 (19.4–23.2) | < 0.0001 |
Serum lactate, mmol/L | 149 | 1.6 (1.1–2.3) | 19 | 3.2 (2.1–6.5) | 130 | 1.5 (1.1–2.1) | < 0.0001 |
Nadir WBC, × 103/μL | 198 | 2.7 (1.94–3.8) | 20 | 2.6 (2.1–4.1) | 178 | 2.7 (1.9–3.7) | 0.47 |
Highest Hct, % | 198 | 45.1 (40.9–49.0) | 20 | 46.9 (41.0–50.2) | 178 | 45.0 (40.9–49.0) | 0.38 |
Nadir Platelet, × 103/μL | 198 | 18 (7–44) | 20 | 7 (2–21) | 178 | 19 (8–45) | 0.005 |
Highest serum creatinine, μmol/L | 198 | 87 (69–112) | 20 | 249 (175–378) | 178 | 83 (68–102) | < 0.0001 |
Highest AST, U/L | 193 | 262 (100–1024) | 20 | 4763 (658–21,547) | 173 | 244 (98–589) | < 0.0001 |
Highest ALT, U/L | 197 | 147 (58–450) | 20 | 1243 (243–3780) | 177 | 117 (55–303) | < 0.0001 |
Highest Troponin T, ng/mL | 22 | 0.01 (0.005–0.3) | 5 | 0.7 (0.1–1.9) | 17 | 0.01 (0.005–0.03) | 0.07 |
Lowest Serum bicarbonate, mmol/L | 195 | 19.5 (16.9–21.4) | 20 | 8.5 (6.7–13.1) | 175 | 19.9 (17.9–21.5) | < 0.0001 |
Highest Serum lactate, mmol/L | 189 | 1.9 (1.3–2.8) | 20 | 16.0 (6.7–18.5) | 169 | 1.8 (1.2–2.3) | < 0.0001 |
Total fluids given, mL | 193 | 6034 (3470–8707) | 20 | 9808 (7184–16,692) | 173 | 5610 (3307–8259) | 0.0004 |